| __timestamp | BioMarin Pharmaceutical Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 19928000 |
| Thursday, January 1, 2015 | 402271000 | 30842000 |
| Friday, January 1, 2016 | 476593000 | 46527000 |
| Sunday, January 1, 2017 | 554336000 | 34451000 |
| Monday, January 1, 2018 | 604353000 | 34409000 |
| Tuesday, January 1, 2019 | 680924000 | 34417000 |
| Wednesday, January 1, 2020 | 737669000 | 145290000 |
| Friday, January 1, 2021 | 759375000 | 298358000 |
| Saturday, January 1, 2022 | 854009000 | 488691000 |
| Sunday, January 1, 2023 | 937300000 | 468946000 |
| Monday, January 1, 2024 | 1009025000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial. BioMarin Pharmaceutical Inc. and Novavax, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, BioMarin's SG&A expenses have surged by over 200%, reflecting its aggressive expansion and investment in new therapies. In contrast, Novavax, while starting with significantly lower expenses, saw a dramatic increase of nearly 2300% by 2022, coinciding with its pivotal role in vaccine development during the COVID-19 pandemic. This divergence highlights BioMarin's steady growth strategy versus Novavax's rapid scaling in response to global health demands. As the biotech landscape evolves, these trends offer insights into how companies balance innovation with financial prudence.
Who Optimizes SG&A Costs Better? Eli Lilly and Company or BioMarin Pharmaceutical Inc.
Eli Lilly and Company and Novavax, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Incyte Corporation and Novavax, Inc.
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Catalent, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs Novavax, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Xencor, Inc. and Novavax, Inc.: SG&A Spending Patterns Compared